Dilabit pharmacy limited-pipeline

07/12/2025

24/09/2024

No more PPI for H Pylori?

The study from the American College of Gastroenterology (ACG) no longer recommends proton pump inhibitors (PPIs) as the preferred treatment for H. pylori infections.

Instead, bismuth quadruple therapy (BQT) is now the first-line treatment due to rising antibiotic resistance, particularly to clarithromycin and levofloxacin.

Bismuth quadruple therapy (BQT) for H. pylori includes the following agents:
1. Bismuth subsalicylate 300 mg, take 1 tablet four times daily.
2. Tetracycline 500 mg, take 1 tablet four times daily.
3. Metronidazole 500 mg, take 1 tablet three times daily.
4. H2-receptor antagonist (e.g., famotidine 20 mg), take 1 tablet twice daily.

05/06/2024

Vitamin D deficiency

08/01/2024

Do not administer Metoclopramide in patients who are on Cabergoline therapy; Metoclopramide is a dopamine antagonist whereas Cabergoline is a dopamine agonist, this will lead to diminshed therapeutic effect of both medications due to “Antagonism”.

Use alternative.